MwanzoBMY • NYSE
add
Bristol-Myers Squibb Co
$ 60.28
Baada ya Saa za Kazi:(0.18%)+0.11
$ 60.39
Imefungwa: 13 Mac, 19:21:08 GMT -4 · USD · NYSE · Kanusho
Bei iliyotangulia
$ 59.80
Bei za siku
$ 59.79 - $ 60.76
Bei za mwaka
$ 39.35 - $ 63.33
Thamani ya kampuni katika soko
122.26B USD
Wastani wa hisa zilizouzwa
12.67M
Uwiano wa bei na mapato
-
Mgao wa faida
4.11%
Ubadilishanaji wa msingi
NYSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 12.34B | 7.54% |
Matumizi ya uendeshaji wa biashara | 6.33B | -7.11% |
Mapato halisi | 72.00M | -95.91% |
Kiwango cha faida halisi | 0.58 | -96.22% |
Mapato kwa kila hisa | 1.67 | -1.76% |
EBITDA | 4.65B | 5.57% |
Asilimia ya kodi ya mapato | 56.57% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 10.86B | -11.57% |
Jumla ya mali | 92.60B | -2.69% |
Jumla ya dhima | 76.22B | 16.05% |
Jumla ya hisa | 16.39B | — |
hisa zilizosalia | 2.03B | — |
Uwiano wa bei na thamani | 7.43 | — |
Faida inayotokana na mali | 7.51% | — |
Faida inayotokana mtaji | 10.26% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 72.00M | -95.91% |
Pesa kutokana na shughuli | 4.44B | 4.40% |
Pesa kutokana na uwekezaji | -196.00M | 85.44% |
Pesa kutokana na ufadhili | -1.64B | -269.80% |
Mabadiliko halisi ya pesa taslimu | 2.45B | -37.89% |
Mtiririko huru wa pesa | 4.24B | -12.74% |
Kuhusu
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders.
BMS's primary research and development sites are located in Lawrence, New Jersey, Summit, New Jersey, formerly HQ of Celgene, New Brunswick, New Jersey; Redwood City, California; and Seville in Spain, with other sites in Devens and Cambridge, Massachusetts; Braine-l'Alleud, Belgium; Tokyo, Japan; Hyderabad; Bangalore, India and Wirral, United Kingdom. BMS previously had an R&D site in Wallingford, Connecticut. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1887
Makao Makuu
Tovuti
Wafanyakazi
34,100
